Investor Relations

Zenabis Presentation

Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Press Releases

Zenabis Closes Previously Announced Public Offering and Exercise of Over-allotment Option

Wednesday April 17, 2019
Zenabis Closes Previously Announced Public Offering and Exercise of Over-allotment Option   /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR…
Read More

Zenabis Files Preliminary Prospectus Supplement for Offering of Common Shares

Wednesday April 10, 2019
Zenabis Files Preliminary Prospectus Supplement for Offering of Common Shares   /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION…
Read More

Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus

Wednesday April 10, 2019
Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus   /NOT FOR DISTRIBUTION TO UNITED STATES…
Read More

Zenabis Global Inc. Announces Resignation of Donald Fairholm from Board of Directors

Monday April 1, 2019
Zenabis Global Inc. Announces Resignation of Donald Fairholm from Board of Directors   VANCOUVER, BC, April 1, 2019 – Zenabis Global Inc.…
Read More

Zenabis Completes $15 million First Tranche of $75 million Convertible Debenture Financing

Wednesday March 27, 2019
Zenabis Completes $15 million First Tranche of $75 million Convertible Debenture Financing   /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR…
Read More

Zenabis Enters European Pharmaceutical Cannabis Market

Thursday March 21, 2019
Zenabis Enters European Pharmaceutical Cannabis Market VANCOUVER, BC, March 21, 2019 – Zenabis Global Inc. (“Zenabis”) (TSXV: ZENA) today announced a significant…
Read More

IRS Form 8937 (US Investor Tax Information)

Issuers of corporate securities are required to complete Internal Revenue Service Form 8937 to report organizational actions, including distributions and reorganizations that affect the basis of the securities involved in the organizational action. The tax information contained herein is provided for informational purposes only and should not be construed as legal or tax advice. Zenabis does not provide legal or tax advice. Please consult your personal tax advisor for assistance as to how this information will impact your specific tax situation.

Download Form

Board Policies

The high standards expected of Zenabis Global Inc., officers, and directors are put in place by the Board of Directors and reflect their core values regarding sound corporate governance. Most prominently reflected in them is an understanding of how the fiduciary responsibility the Company has to shareholders receives as much emphasis as the effective and forward-thinking management of company business. The following guidelines details standards and procedures that are in line with this dual-focus approach to operating the company catering to both interests equally. Do note that they may be amended when and as necessary based on the Company's interests or to be in accordance with applicable laws and regulations.

GET THE CORPORATE NEWSLETTER

Want to keep in touch? We'll send you our latest updates. You can unsubscribe at any time.

Consent